Transcend Capital Advisors’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-500
Closed -$17.4K 504
2023
Q2
$17.4K Hold
500
﹤0.01% 483
2023
Q1
$10.9K Hold
500
﹤0.01% 478
2022
Q4
$10.8K Hold
500
﹤0.01% 489
2022
Q3
$12K Hold
500
﹤0.01% 478
2022
Q2
$10K Hold
500
﹤0.01% 495
2022
Q1
$18K Hold
500
﹤0.01% 514
2021
Q4
$14K Buy
+500
New +$14K ﹤0.01% 487